Estimate Recalculated Nov 11, 2024 01:47PM EST
Aaron Royston does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Ventyx Biosciences, Inc., Akero Therapeutics, Inc., Menlo Therapeutics Inc., Elevation Oncology, Inc., and RayzeBio, Inc..
Aaron Royston's CIK is 0001727703
2022 was Aaron Royston's most active year for acquiring shares with 2 total transactions. Aaron Royston's most active month to acquire stocks was the month of May. 2019 saw Aaron Royston paying a total of $0.00 for 22,500 shares, this is the most they've acquired in one year.
No data available
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!